Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia.
A prospective, randomized study was undertaken to compare the efficacy and safety of ceftazidime with those of a combination of ticarcillin and tobramycin in the treatment of 40 nonneutropenic patients with pneumonia or bacteremia. Altogether, 93% of the patients receiving ceftazidime for pneumonia...
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1985
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176304/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3899005/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.28.1.33 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
